Comparison of Cak1p-like cyclin-dependent kinase-activating kinases

被引:33
|
作者
Tsakraklides, V
Solomon, MJ
机构
[1] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA
关键词
D O I
10.1074/jbc.M205537200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinases (cdks) coordinate progression through the eukaryotic cell cycle and require phosphorylation by a cdk-activating kinase (CAK) for full activity. In most eukaryotes Cdk7 is the catalytic subunit of a heterotrimeric CAK (Cdk7-cyclin H-Mat1) that is also involved in transcription as part of the transcription factor IIH complex. The Saccharomyces cerevisiae CAK, Cak1p, is a monomeric protein kinase with an atypical sequence and unusual biochemical properties compared with trimeric CAKs and other protein kinases. We sought to determine whether these properties were shared by a small group of monomeric CAKs that can function in place of CAK1 in S. cerevisiae. We found that Schizosaccharomyces pombe Csk1, Candida albicans Cak1, and Arabidopsis thaliana Cak1At, like Cak1p, all displayed a preference for cyclin-free cdk substrates, were insensitive to the protein kinase inhibitor 5'-fluorosulfonylbenzoyladenosine (FSBA), and were insensitive to mutation of a highly conserved lysine residue found in the nucleotide binding pocket of all protein kinases. The S. pombe and C. albicans kinases also resembled Cak1p in their kinetics of nucleotide and protein substrate utilization. Conservation of these unusual properties in fungi and plants points to shared evolutionary requirements not met by Cdk7 and raises the possibility of developing antifungal agents targeting CAKs.
引用
收藏
页码:33482 / 33489
页数:8
相关论文
共 50 条
  • [21] Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
    Mandal, M
    Bandyopadhyay, D
    Goepfert, TM
    Kumar, R
    ONCOGENE, 1998, 16 (02) : 217 - 225
  • [22] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [23] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    Molecular Biotechnology, 2001, 19 : 179 - 188
  • [24] Cyclin dependent kinase activating kinases
    Sclafani, RA
    CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) : 788 - 794
  • [25] BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE
    APRELIKOVA, O
    XIONG, Y
    LIU, ET
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18195 - 18197
  • [26] Lower cyclin H and cyclin-dependent kinase-activating kinase activity in cell cycle arrest induced by lack of adhesion to substratum
    Solorzano, L
    Rieber, MS
    Rieber, M
    CANCER RESEARCH, 2000, 60 (24) : 7114 - 7118
  • [27] The rice cyclin-dependent kinase-activating kinase R2 regulates S-phase progression
    Fabian-Marwedel, T
    Umeda, M
    Sauter, M
    PLANT CELL, 2002, 14 (01): : 197 - 210
  • [28] Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas
    Kudo, Y
    Yasui, W
    Ue, T
    Yamamoto, S
    Yokozaki, H
    Nikai, H
    Tahara, E
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (10): : 947 - 952
  • [29] The Arabidopsis cyclin-dependent kinase-activating kinase CDKF;1 is a major regulator of cell proliferation and cell expansion but is dispensable for CDKA activation
    Takatsuka, Hirotomo
    Ohno, Ryoko
    Umeda, Masaaki
    PLANT JOURNAL, 2009, 59 (03): : 475 - 487
  • [30] Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans
    Fiano, V
    Ghimenti, C
    Schiffer, D
    NEUROSCIENCE LETTERS, 2003, 347 (02) : 111 - 115